Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial.
| Image |  |
|---|---|
| Description | scientific article published on 19 December 2016 |
| Author/s |
author: Lisa Belin Olivier Trédan Vincent Servois |
| Publication date | March 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |